Email Facebook Twitter

Member Info for inanaco

Premium Member

Member Since: Wed, 19th Oct 2011

Number of Share Chat Posts (all time): 22,798
Number of Share Chat Posts (last 30 days): 994

Last Posted: Tue 21:33

Post Distribution over the last 30 days

Tue 21:33

well it just so happens there are a few around ...
Tue 21:24

If the science In your opinion .. is validated why do you persist in asking such daft questions ... as its in unmet clinical need .. orphan status .. how can it fail ??
Tue 21:06

Go into receivership .. simple answer ...
Tue 19:58

good reply .. I could not be bothered ... if bunsie has got his head around scancell after all he has been in since 2010 which i find hard to believe, if you did believe it, why would he ask that question ...?
Tue 19:52

The market is always changing ... keeping abreast with what's current is vital ... and what is current is changing the oncology market ..

Sign up for Live Prices
Top Recommended
Hot Chat Topics
Top recommended posters in the last 30 days
Share Price SpacerBigGib596 
Share Price SpacerK3VMC481 
Share Price SpacerLongTermHolder477 
Share Price Spacerseanhunter465 
Share Price SpacerXavierX457 
Share Price SpacerBelcourtoi456 
Share Price Spacerriddler419 
Share Price SpacerMarty4212407 

Member Login

Forgotten your password?


Don't have an account? Click here to Register Free!

Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy

Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.